Is progression-free survival associated with a better health-related quality of life in patients with lung cancer? Evidence from two randomised trials with afatinib.
about
Sociodemographic and Clinical Determinants of Quality of Life of Patients with Non-small Cell Lung Cancer.Nonprogression with avelumab treatment associated with gains in quality of life in metastatic Merkel cell carcinoma.Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients
P2860
Is progression-free survival associated with a better health-related quality of life in patients with lung cancer? Evidence from two randomised trials with afatinib.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Is progression-free survival a ...... ndomised trials with afatinib.
@ast
Is progression-free survival a ...... ndomised trials with afatinib.
@en
Is progression-free survival a ...... ndomised trials with afatinib.
@nl
type
label
Is progression-free survival a ...... ndomised trials with afatinib.
@ast
Is progression-free survival a ...... ndomised trials with afatinib.
@en
Is progression-free survival a ...... ndomised trials with afatinib.
@nl
prefLabel
Is progression-free survival a ...... ndomised trials with afatinib.
@ast
Is progression-free survival a ...... ndomised trials with afatinib.
@en
Is progression-free survival a ...... ndomised trials with afatinib.
@nl
P2093
P2860
P1433
P1476
Is progression-free survival a ...... andomised trials with afatinib
@en
P2093
Ingolf Griebsch
Michael Palmer
Stuart Ellis
P2860
P304
P356
10.1136/BMJOPEN-2014-005762
P577
2014-10-31T00:00:00Z